Skip to main content
Caplight Logo









OneSkin

OneSkin

Private
San Francisco, CaliforniaConsumer & Commercehttps://www.oneskin.co/

Last Round

Series A

Extension

Aug 7, 2025

Est. Valuation

$142.31M

Total Funding Raised

$49.25M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

OneSkin is a biotechnology company that develops and sells topical skin supplements designed to reverse skin's biological age at the molecular level.

Sector

Consumer & Commerce

Verticals

Biotechnology, Fashion & Beauty, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

longevity skincarecellular senescencepeptide skincareanti-agingDTC skincareskin longevitybiohackingscience-backed skincaresubscription skincarebiological agebiotechnologyMolClockclinical skincare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OneSkin Comparables

Compare OneSkin with similar companies based on industry and business-model similarity.

OneSkin comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eighth Day
82%
Mblue Labs
81%
Aramore Skincare
80%

OneSkin Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionAug 7, 2025
Series AJul 1, 2025
Series ANov 13, 2024
SeedOct 26, 2022
SeedMay 8, 2017
Accelerator
Jul 1, 2016

Key People

Founding team and executive leadership

Carolina Reis Oliveira

Founder And CEO

Founding Team

Michael S. Lee

Chief Operating Officer

Executive Team

OneSkin Investors

Notable investors and investment history

OneSkin investors
InvestorRounds
Selva VenturesSeries A
Able PartnersSeries A
Plus CapitalSeries A
Metaplanet HoldingsSeries A
Prelude Growth PartnersSeries A, Series A Extension
IndieBioSeed, Accelerator
SOSVAccelerator, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 44% MoM.

  • Oct 1, 2025

    Proprietary peptide claims to be first to reduce biological age of human skin.

OneSkin Filings

Explore SEC and related filing metadata, where available.

OneSkin filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OneSkin's valuation, stock price, and market status.

Is OneSkin a public or private company?

OneSkin is a private company.

What is the current stock price of OneSkin?

OneSkin is a private company with no public stock price. No recent secondary market data is available.

How much is OneSkin worth (valuation)?

Valuation information for OneSkin is not publicly available.

Can I buy OneSkin stock?

OneSkin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OneSkin's last funding round?

OneSkin's most recent funding round was Series A Extension on August 7, 2025.

Who are the main investors in OneSkin?

Key investors in OneSkin include Selva Ventures, Prelude Growth Partners, IndieBio.

Will OneSkin IPO soon?

No public IPO plans have been announced for OneSkin.

How can I track OneSkin secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OneSkin's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range52
Year Founded2016
Last FundingAug 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?